Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
PLoS Pathog ; 19(10): e1011435, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37906600

ABSTRACT

The Aspergillus fumigatus unfolded protein response (UPR) is a two-component relay consisting of the ER-bound IreA protein, which splices and activates the mRNA of the transcription factor HacA. Spliced hacA accumulates under conditions of acute ER stress in vitro, and UPR null mutants are hypovirulent in a murine model of invasive pulmonary infection. In this report, we demonstrate that a hacA deletion mutant (ΔhacA) is furthermore avirulent in a model of fungal keratitis, a corneal infection, and an important cause of ocular morbidity and unilateral blindness worldwide. Interestingly, we demonstrate that A. fumigatus hacA is spliced in infected lung samples, but not in the cornea, suggesting the amount of ER stress experienced by the fungus varies upon the host niche. To better understand how the UPR contributes to fungal cell biology across a spectrum of ER-stress levels, we employed transcriptomics on the wild-type and ΔhacA strains in glucose minimal media (low stress), glucose minimal media with dithiothreitol (high stress), and gelatin minimal media as a proxy for the nutrient stress encountered in the cornea (mid-level stress). These data altogether reveal a unique HacA-dependent transcriptome under each condition, suggesting that HacA activity is finely-tuned and required for proper fungal adaptation in each environment. Taken together, our results indicate that the fungal UPR could serve as an important antifungal target in the setting of both invasive pulmonary and corneal infections.


Subject(s)
Aspergillus fumigatus , Keratitis , Animals , Mice , Unfolded Protein Response , Keratitis/genetics , Nutrients , Glucose/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism
2.
Pediatr Dev Pathol ; 24(5): 493-497, 2021.
Article in English | MEDLINE | ID: mdl-34047234

ABSTRACT

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a highly aggressive malignant tumor affecting predominantly young adults and adolescents with an average age of 23.9 at time of diagnosis. Up to two thirds of patients have paraneoplastic hypercalcemia. The molecular signature of these tumors is SMARCA4 mutations, with somatic and germline pathogenic variants previously described. We report a case of a previously healthy one-year-old girl who was noticed to have mild anemia and an abdominal mass during a well-child visit. Further laboratory testing revealed hypercalcemia. A computerized tomography scan showed a left-sided ovarian mass (9.3 x 7.3 x 7 cm). The resection specimen showed a large ovarian tumor with solid tan-yellow cut surfaces and small foci of necrosis. Microscopically, the tumor was composed of sheets of small, hyperchromatic epithelioid cells with focal rhabdoid large cell morphology. The tumor cells were strongly and diffusely positive for WT1 (N-terminal antibodies) with focal EMA and Pan-keratin positivity. Absent SMARCA4 (BRG1) protein expression by immunohistochemistry ultimately established the diagnosis of small cell carcinoma of the ovary, hypercalcemic type. To our knowledge, this is the youngest patient reported in the literature.


Subject(s)
Carcinoma, Small Cell/diagnosis , Hypercalcemia/etiology , Ovarian Neoplasms/diagnosis , Paraneoplastic Syndromes/etiology , Biomarkers, Tumor/metabolism , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/metabolism , Carcinoma, Small Cell/pathology , DNA Helicases/metabolism , Female , Humans , Hypercalcemia/diagnosis , Infant , Nuclear Proteins/metabolism , Ovarian Neoplasms/complications , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Paraneoplastic Syndromes/diagnosis , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL